A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
NuCana plc
Calithera Biosciences, Inc